Pharma & Healthcare
Global Maternal Pertussis Vaccine for Newborn Protection Market Research Report 2026
- Feb 24, 26
- ID: 708747
- Pages: 116
- Figures: 111
- Views: 1
This report delivers a comprehensive overview of the global Maternal Pertussis Vaccine for Newborn Protection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Maternal Pertussis Vaccine for Newborn Protection. The Maternal Pertussis Vaccine for Newborn Protection market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Maternal Pertussis Vaccine for Newborn Protection market comprehensively. Regional market sizes by Type, by Application, by Composition, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Maternal Pertussis Vaccine for Newborn Protection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Composition
Acellular Vaccines
Whole-cell Vaccines
Segment by User
Below 12 Months
Above 12 Months
by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Composition, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Maternal Pertussis Vaccine for Newborn Protection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Maternal Pertussis Vaccine for Newborn Protection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Maternal Pertussis Vaccine for Newborn Protection market comprehensively. Regional market sizes by Type, by Application, by Composition, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Maternal Pertussis Vaccine for Newborn Protection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Composition
Acellular Vaccines
Whole-cell Vaccines
Segment by User
Below 12 Months
Above 12 Months
by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Composition, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Maternal Pertussis Vaccine for Newborn Protection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Maternal Pertussis Vaccine for Newborn Protection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Maternal Pertussis Vaccine for Newborn Protection Market Overview
1.1 Product Definition
1.2 Maternal Pertussis Vaccine for Newborn Protection by Type
1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Type: 2025 vs 2032
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 Maternal Pertussis Vaccine for Newborn Protection by Composition
1.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition: 2025 vs 2032
1.3.2 Acellular Vaccines
1.3.3 Whole-cell Vaccines
1.4 Maternal Pertussis Vaccine for Newborn Protection by User
1.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User: 2025 vs 2032
1.4.2 Below 12 Months
1.4.3 Above 12 Months
1.5 Maternal Pertussis Vaccine for Newborn Protection by Application
1.5.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.6 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Estimates and Forecasts
1.6.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue 2021–2032
1.6.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales 2021–2032
1.6.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Maternal Pertussis Vaccine for Newborn Protection Market Competition by Manufacturers
2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Types and Applications
2.7 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Entry into the Industry
2.8 Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation and Trends
2.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue
2.8.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Maternal Pertussis Vaccine for Newborn Protection Market Scenario by Region
3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021–2032
3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021–2026
3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2027–2032
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021–2032
3.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021–2026
3.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2027–2032
3.4 North America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.4.3 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.5.3 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Region
3.6.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021–2032)
3.6.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.7.1 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.7.3 Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.8.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021–2032)
4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021–2026)
4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027–2032)
4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021–2032)
4.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021–2032)
4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021–2026)
4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027–2032)
4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021–2032)
4.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021–2032)
5.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021–2026)
5.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027–2032)
5.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021–2032)
5.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021–2032)
5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021–2026)
5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027–2032)
5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021–2032)
5.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Maternal Pertussis Vaccine for Newborn Protection Industry Chain Analysis
7.2 Maternal Pertussis Vaccine for Newborn Protection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process Analysis
7.4 Maternal Pertussis Vaccine for Newborn Protection Sales and Marketing
7.4.1 Maternal Pertussis Vaccine for Newborn Protection Sales Channels
7.4.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
7.5 Maternal Pertussis Vaccine for Newborn Protection Customer Analysis
8 Maternal Pertussis Vaccine for Newborn Protection Market Dynamics
8.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
8.2 Maternal Pertussis Vaccine for Newborn Protection Market Drivers
8.3 Maternal Pertussis Vaccine for Newborn Protection Market Challenges
8.4 Maternal Pertussis Vaccine for Newborn Protection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Maternal Pertussis Vaccine for Newborn Protection by Type
1.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Type: 2025 vs 2032
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 Maternal Pertussis Vaccine for Newborn Protection by Composition
1.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition: 2025 vs 2032
1.3.2 Acellular Vaccines
1.3.3 Whole-cell Vaccines
1.4 Maternal Pertussis Vaccine for Newborn Protection by User
1.4.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User: 2025 vs 2032
1.4.2 Below 12 Months
1.4.3 Above 12 Months
1.5 Maternal Pertussis Vaccine for Newborn Protection by Application
1.5.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.6 Global Maternal Pertussis Vaccine for Newborn Protection Market Size Estimates and Forecasts
1.6.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue 2021–2032
1.6.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales 2021–2032
1.6.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Maternal Pertussis Vaccine for Newborn Protection Market Competition by Manufacturers
2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Maternal Pertussis Vaccine for Newborn Protection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Types and Applications
2.7 Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Entry into the Industry
2.8 Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation and Trends
2.8.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Maternal Pertussis Vaccine for Newborn Protection Players Market Share by Revenue
2.8.3 Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Maternal Pertussis Vaccine for Newborn Protection Market Scenario by Region
3.1 Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021–2032
3.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2021–2026
3.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region: 2027–2032
3.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021–2032
3.3.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021–2026
3.3.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2027–2032
3.4 North America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.4.1 North America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.4.3 North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.5.1 Europe Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.5.3 Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Region
3.6.1 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (2021–2032)
3.6.3 Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.7.1 Latin America Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.7.3 Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Facts & Figures by Country
3.8.1 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021–2032)
4.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2021–2026)
4.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Type (2027–2032)
4.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021–2032)
4.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021–2032)
4.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2021–2026)
4.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Type (2027–2032)
4.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021–2032)
4.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021–2032)
5.1.1 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2021–2026)
5.1.2 Global Maternal Pertussis Vaccine for Newborn Protection Sales by Application (2027–2032)
5.1.3 Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021–2032)
5.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021–2032)
5.2.1 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2021–2026)
5.2.2 Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Application (2027–2032)
5.2.3 Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021–2032)
5.3 Global Maternal Pertussis Vaccine for Newborn Protection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Maternal Pertussis Vaccine for Newborn Protection Industry Chain Analysis
7.2 Maternal Pertussis Vaccine for Newborn Protection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Maternal Pertussis Vaccine for Newborn Protection Production Mode & Process Analysis
7.4 Maternal Pertussis Vaccine for Newborn Protection Sales and Marketing
7.4.1 Maternal Pertussis Vaccine for Newborn Protection Sales Channels
7.4.2 Maternal Pertussis Vaccine for Newborn Protection Distributors
7.5 Maternal Pertussis Vaccine for Newborn Protection Customer Analysis
8 Maternal Pertussis Vaccine for Newborn Protection Market Dynamics
8.1 Maternal Pertussis Vaccine for Newborn Protection Industry Trends
8.2 Maternal Pertussis Vaccine for Newborn Protection Market Drivers
8.3 Maternal Pertussis Vaccine for Newborn Protection Market Challenges
8.4 Maternal Pertussis Vaccine for Newborn Protection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition (US$ Million), 2025 vs 2032
Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User (US$ Million), 2025 vs 2032
Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation by Manufacturers in 2025
Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) of Key Manufacturers (2021–2026)
Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Types and Applications
Table 14. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Maternal Pertussis Vaccine for Newborn Protection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Maternal Pertussis Vaccine for Newborn Protection Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2021–2026
Table 20. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021–2026)
Table 21. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2027–2032
Table 22. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2027–2032)
Table 23. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2021–2026
Table 24. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021–2026)
Table 25. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2027–2032
Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2027–2032)
Table 27. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 29. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 30. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 31. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 34. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 35. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2021–2026
Table 39. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2027–2032
Table 40. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 44. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 45. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 49. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 50. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Type (2021–2026)
Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Type (2027–2032)
Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021–2026)
Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2027–2032)
Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021–2026)
Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2027–2032)
Table 60. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2021–2026)
Table 61. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2027–2032)
Table 62. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Application (2021–2026)
Table 63. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Application (2027–2032)
Table 64. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021–2026)
Table 65. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2027–2032)
Table 66. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021–2026)
Table 69. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2027–2032)
Table 70. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2021–2026)
Table 71. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2027–2032)
Table 72. Sanofi Pasteur Company Information
Table 73. Sanofi Pasteur Description and Business Overview
Table 74. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 75. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product
Table 76. Sanofi Pasteur Recent Developments/Updates
Table 77. GSK Company Information
Table 78. GSK Description and Business Overview
Table 79. GSK Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 80. GSK Maternal Pertussis Vaccine for Newborn Protection Product
Table 81. GSK Recent Developments/Updates
Table 82. Mitsubishi Tanabe Pharma Company Information
Table 83. Mitsubishi Tanabe Pharma Description and Business Overview
Table 84. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 85. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product
Table 86. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 87. KM Biologics Company Information
Table 88. KM Biologics Description and Business Overview
Table 89. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 90. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product
Table 91. KM Biologics Recent Developments/Updates
Table 92. Wuhan Institute of Biological Products Company Information
Table 93. Wuhan Institute of Biological Products Description and Business Overview
Table 94. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 95. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product
Table 96. Wuhan Institute of Biological Products Recent Developments/Updates
Table 97. Walvax Biotechnology Company Information
Table 98. Walvax Biotechnology Description and Business Overview
Table 99. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 100. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product
Table 101. Walvax Biotechnology Recent Developments/Updates
Table 102. Chengdu Institute of Biological Products Company Information
Table 103. Chengdu Institute of Biological Products Description and Business Overview
Table 104. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 105. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product
Table 106. Chengdu Institute of Biological Products Recent Developments/Updates
Table 107. Minhai Biotechnology Company Information
Table 108. Minhai Biotechnology Description and Business Overview
Table 109. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 110. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product
Table 111. Minhai Biotechnology Recent Developments/Updates
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Maternal Pertussis Vaccine for Newborn Protection Distributors List
Table 115. Maternal Pertussis Vaccine for Newborn Protection Customers List
Table 116. Maternal Pertussis Vaccine for Newborn Protection Market Trends
Table 117. Maternal Pertussis Vaccine for Newborn Protection Market Drivers
Table 118. Maternal Pertussis Vaccine for Newborn Protection Market Challenges
Table 119. Maternal Pertussis Vaccine for Newborn Protection Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Authors List of This Report
List of Figures
Figure 1. Product Picture of Maternal Pertussis Vaccine for Newborn Protection
Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type: 2025 & 2032
Figure 4. DTaP Product Picture
Figure 5. Tdap Product Picture
Figure 6. DTwP Product Picture
Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition (US$ Million), 2021–2032
Figure 8. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Composition: 2025 vs 2032
Figure 9. Acellular Vaccines Product Picture
Figure 10. Whole-cell Vaccines Product Picture
Figure 11. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User (US$ Million), 2021–2032
Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by User: 2025 vs 2032
Figure 13. Below 12 Months Product Picture
Figure 14. Above 12 Months Product Picture
Figure 15. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application: 2025 & 2032
Figure 17. Hospital
Figure 18. Clinic
Figure 19. Global Maternal Pertussis Vaccine for Newborn Protection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (US$ Million), 2021–2032
Figure 21. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), 2021–2032
Figure 22. Global Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose), 2021–2032
Figure 23. Maternal Pertussis Vaccine for Newborn Protection Report Years Considered
Figure 24. Maternal Pertussis Vaccine for Newborn Protection Sales Share by Manufacturers in 2025
Figure 25. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers in 2025
Figure 26. Top 5 and Top 10 Global Maternal Pertussis Vaccine for Newborn Protection Players: Market Share by Revenue in Maternal Pertussis Vaccine for Newborn Protection in 2025
Figure 27. Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 29. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 30. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 31. United States Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 34. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 35. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. France Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. U.K. Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021–2032)
Figure 41. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021–2032)
Figure 42. China Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. India Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. China Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 50. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 51. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Argentina Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Colombia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 56. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 57. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. UAE Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2021–2032)
Figure 61. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2021–2032)
Figure 62. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2021–2032)
Figure 63. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2021–2032)
Figure 64. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2021–2032)
Figure 65. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2021–2032)
Figure 66. Maternal Pertussis Vaccine for Newborn Protection Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition (US$ Million), 2025 vs 2032
Table 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User (US$ Million), 2025 vs 2032
Table 4. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Maternal Pertussis Vaccine for Newborn Protection Market Competitive Situation by Manufacturers in 2025
Table 6. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) of Key Manufacturers (2021–2026)
Table 7. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Maternal Pertussis Vaccine for Newborn Protection, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Product Types and Applications
Table 14. Global Key Manufacturers of Maternal Pertussis Vaccine for Newborn Protection, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Maternal Pertussis Vaccine for Newborn Protection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Maternal Pertussis Vaccine for Newborn Protection Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2021–2026
Table 20. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021–2026)
Table 21. Global Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2027–2032
Table 22. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2027–2032)
Table 23. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2021–2026
Table 24. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021–2026)
Table 25. Global Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2027–2032
Table 26. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2027–2032)
Table 27. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 29. North America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 30. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 31. North America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 34. Europe Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 35. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2021–2026
Table 39. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales by Region (K Dose), 2027–2032
Table 40. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 44. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 45. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2021–2026
Table 49. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales by Country (K Dose), 2027–2032
Table 50. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue by Country (US$ Million), 2027–2032
Table 52. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Type (2021–2026)
Table 53. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Type (2027–2032)
Table 54. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2021–2026)
Table 55. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Type (2027–2032)
Table 56. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2021–2026)
Table 59. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Type (2027–2032)
Table 60. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2021–2026)
Table 61. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2027–2032)
Table 62. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Application (2021–2026)
Table 63. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose) by Application (2027–2032)
Table 64. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2021–2026)
Table 65. Global Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Application (2027–2032)
Table 66. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Maternal Pertussis Vaccine for Newborn Protection Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2021–2026)
Table 69. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Application (2027–2032)
Table 70. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2021–2026)
Table 71. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2027–2032)
Table 72. Sanofi Pasteur Company Information
Table 73. Sanofi Pasteur Description and Business Overview
Table 74. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 75. Sanofi Pasteur Maternal Pertussis Vaccine for Newborn Protection Product
Table 76. Sanofi Pasteur Recent Developments/Updates
Table 77. GSK Company Information
Table 78. GSK Description and Business Overview
Table 79. GSK Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 80. GSK Maternal Pertussis Vaccine for Newborn Protection Product
Table 81. GSK Recent Developments/Updates
Table 82. Mitsubishi Tanabe Pharma Company Information
Table 83. Mitsubishi Tanabe Pharma Description and Business Overview
Table 84. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 85. Mitsubishi Tanabe Pharma Maternal Pertussis Vaccine for Newborn Protection Product
Table 86. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 87. KM Biologics Company Information
Table 88. KM Biologics Description and Business Overview
Table 89. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 90. KM Biologics Maternal Pertussis Vaccine for Newborn Protection Product
Table 91. KM Biologics Recent Developments/Updates
Table 92. Wuhan Institute of Biological Products Company Information
Table 93. Wuhan Institute of Biological Products Description and Business Overview
Table 94. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 95. Wuhan Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product
Table 96. Wuhan Institute of Biological Products Recent Developments/Updates
Table 97. Walvax Biotechnology Company Information
Table 98. Walvax Biotechnology Description and Business Overview
Table 99. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 100. Walvax Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product
Table 101. Walvax Biotechnology Recent Developments/Updates
Table 102. Chengdu Institute of Biological Products Company Information
Table 103. Chengdu Institute of Biological Products Description and Business Overview
Table 104. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 105. Chengdu Institute of Biological Products Maternal Pertussis Vaccine for Newborn Protection Product
Table 106. Chengdu Institute of Biological Products Recent Developments/Updates
Table 107. Minhai Biotechnology Company Information
Table 108. Minhai Biotechnology Description and Business Overview
Table 109. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 110. Minhai Biotechnology Maternal Pertussis Vaccine for Newborn Protection Product
Table 111. Minhai Biotechnology Recent Developments/Updates
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Maternal Pertussis Vaccine for Newborn Protection Distributors List
Table 115. Maternal Pertussis Vaccine for Newborn Protection Customers List
Table 116. Maternal Pertussis Vaccine for Newborn Protection Market Trends
Table 117. Maternal Pertussis Vaccine for Newborn Protection Market Drivers
Table 118. Maternal Pertussis Vaccine for Newborn Protection Market Challenges
Table 119. Maternal Pertussis Vaccine for Newborn Protection Market Restraints
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Authors List of This Report
List of Figures
Figure 1. Product Picture of Maternal Pertussis Vaccine for Newborn Protection
Figure 2. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Type: 2025 & 2032
Figure 4. DTaP Product Picture
Figure 5. Tdap Product Picture
Figure 6. DTwP Product Picture
Figure 7. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Composition (US$ Million), 2021–2032
Figure 8. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Composition: 2025 vs 2032
Figure 9. Acellular Vaccines Product Picture
Figure 10. Whole-cell Vaccines Product Picture
Figure 11. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by User (US$ Million), 2021–2032
Figure 12. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by User: 2025 vs 2032
Figure 13. Below 12 Months Product Picture
Figure 14. Above 12 Months Product Picture
Figure 15. Global Maternal Pertussis Vaccine for Newborn Protection Market Value by Application (US$ Million), 2021–2032
Figure 16. Global Maternal Pertussis Vaccine for Newborn Protection Market Share by Application: 2025 & 2032
Figure 17. Hospital
Figure 18. Clinic
Figure 19. Global Maternal Pertussis Vaccine for Newborn Protection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 20. Global Maternal Pertussis Vaccine for Newborn Protection Market Size (US$ Million), 2021–2032
Figure 21. Global Maternal Pertussis Vaccine for Newborn Protection Sales (K Dose), 2021–2032
Figure 22. Global Maternal Pertussis Vaccine for Newborn Protection Average Price (US$/Dose), 2021–2032
Figure 23. Maternal Pertussis Vaccine for Newborn Protection Report Years Considered
Figure 24. Maternal Pertussis Vaccine for Newborn Protection Sales Share by Manufacturers in 2025
Figure 25. Global Maternal Pertussis Vaccine for Newborn Protection Revenue Share by Manufacturers in 2025
Figure 26. Top 5 and Top 10 Global Maternal Pertussis Vaccine for Newborn Protection Players: Market Share by Revenue in Maternal Pertussis Vaccine for Newborn Protection in 2025
Figure 27. Maternal Pertussis Vaccine for Newborn Protection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 28. Global Maternal Pertussis Vaccine for Newborn Protection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 29. North America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 30. North America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 31. United States Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Canada Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Europe Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 34. Europe Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 35. Germany Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. France Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. U.K. Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Italy Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Russia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Region (2021–2032)
Figure 41. Asia Pacific Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Region (2021–2032)
Figure 42. China Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Japan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. South Korea Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. India Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Australia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. China Taiwan Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Southeast Asia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Latin America Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 50. Latin America Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 51. Mexico Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Brazil Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Argentina Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Colombia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Sales Market Share by Country (2021–2032)
Figure 56. Middle East and Africa Maternal Pertussis Vaccine for Newborn Protection Revenue Market Share by Country (2021–2032)
Figure 57. Turkey Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Saudi Arabia Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. UAE Maternal Pertussis Vaccine for Newborn Protection Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2021–2032)
Figure 61. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Type (2021–2032)
Figure 62. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Type (2021–2032)
Figure 63. Global Sales Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2021–2032)
Figure 64. Global Revenue Market Share of Maternal Pertussis Vaccine for Newborn Protection by Application (2021–2032)
Figure 65. Global Maternal Pertussis Vaccine for Newborn Protection Price (US$/Dose) by Application (2021–2032)
Figure 66. Maternal Pertussis Vaccine for Newborn Protection Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Extruded Grade PETG Market Research Report 2026
Feb 24, 26
Global Particle Testing & Analysis Market Research Report 2026
Feb 24, 26
Global Plastic Lens for Automotive Lights Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232